Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-17 3:20 pm Purchase | 2023-02-08 | 13G | AVROBIO, Inc. AVRO | Farallon Capital Partners, L.P. | 259,667 7.100% | 259,667![]() (New Position) | Filing History |
2023-02-14 08:27 am Sale | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners, L.P. | 3,399,921 4.800% | -151,850![]() (-4.28%) | Filing History |
2023-02-09 4:55 pm Unchanged | 2022-12-31 | 13G | Shelter Acquisition Corporation I SHQA | Farallon Capital Partners, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
2023-02-09 4:55 pm Purchase | 2022-12-31 | 13G | Swiftmerge Acquisition Corp. IVCP | Farallon Capital Partners, L.P. | 2,205,000 9.700% | 2,205,000![]() (New Position) | Filing History |
2023-02-09 4:54 pm Purchase | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Farallon Capital Partners, L.P. | 5,055,102 9.990% | 5,055,102![]() (New Position) | Filing History |
2023-02-07 5:10 pm Sale | 2022-12-31 | 13G | Better Therapeutics, Inc. BTTX | Farallon Capital Partners, L.P. | 813,556 3.400% | -536,444![]() (-39.74%) | Filing History |
2023-02-07 5:09 pm Sale | 2022-12-31 | 13G | Clarivate Plc CLVT | Farallon Capital Partners, L.P. | 15,177,433 2.300% | -20,148,467![]() (-57.04%) | Filing History |
2023-02-07 5:09 pm Purchase | 2022-12-31 | 13G | AMYRIS INC AMRSQ | Farallon Capital Partners, L.P. | 1,000,000 0.300% | 1,000,000![]() (New Position) | Filing History |
2023-02-06 4:20 pm Unchanged | 2022-12-31 | 13G | SEP Acquisition Corp. SEPA | Farallon Capital Partners, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
2023-02-06 09:06 am Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 1,550,000 7.500% | 1,550,000![]() (New Position) | Filing History |
2023-02-03 5:16 pm Purchase | 2022-12-31 | 13G | Savara Inc. SVRA | Farallon Capital Partners, L.P. | 11,532,622 9.990% | 11,532,622![]() (New Position) | Filing History |
2023-02-03 5:15 pm Sale | 2022-12-31 | 13G | Aramark ARMK | Farallon Capital Partners, L.P. | 14,998,004 4.200% | -7,593,263![]() (-33.61%) | Filing History |
2023-02-03 5:15 pm Purchase | 2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Farallon Capital Partners, L.P. | 1,417,917 9.990% | 1,417,917![]() (New Position) | Filing History |
2023-02-01 5:16 pm Sale | 2022-12-31 | 13G | Imago BioSciences, Inc. IMGO | Farallon Capital Partners, L.P. | 0 0.000% | -2,671,313![]() (Position Closed) | Filing History |
2023-02-01 5:12 pm Purchase | 2022-12-31 | 13G | Generation Bio Co. GBIO | Farallon Capital Partners, L.P. | 1,249,382 2.100% | 1,249,382![]() (New Position) | Filing History |
2023-02-01 5:09 pm Unchanged | 2022-12-31 | 13G | Big Sky Growth Partners, Inc. BSKYW | Farallon Capital Partners, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
2023-01-31 5:18 pm Purchase | 2022-12-31 | 13G | Disruptive Acquisition Corporation I DISA | Farallon Capital Partners, L.P. | 1,400,000 5.100% | 1,400,000![]() (New Position) | Filing History |
2023-01-31 5:14 pm Purchase | 2022-12-31 | 13G | Berenson Acquisition Corp. I BACA | Farallon Capital Partners, L.P. | 2,662,500 9.600% | 2,662,500![]() (New Position) | Filing History |
2023-01-31 5:09 pm Unchanged | 2022-12-31 | 13G | ARYA Sciences Acquisition Corp IV ARYD | Farallon Capital Partners, L.P. | 800,000 5.200% | 0 (Unchanged) | Filing History |
2022-10-07 3:12 pm Purchase | 2022-09-29 | 13D | Change Healthcare Inc. CHNG | Farallon Capital Partners, L.P. | 18,076,272 5.500% | 18,076,272![]() (New Position) | Filing History |